Status:
COMPLETED
Redes III Patient Navigator Qol Study
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proposed 5-year Redes En Acción research study involves a mixed-methods approach that occurs in two phases across two distinct and diverse HL communities. The RCT involves a 2 X 4 randomized repe...
Detailed Description
Hispanic/Latinos (HL) are the largest and fastest-growing minority population in the nation. HLs generally have lower survival rates for most cancers, even after accounting for differences in age and ...
Eligibility Criteria
Inclusion
- Self identified Hispanic/Latino
- At least 18 yrs old
- Fluent in spoken Spanish or English
- Diagnosed with breast, prostate or colorectal cancer within the past fifteen months and thus considered a cancer survivor and are currently not undergoing treatment, with the exception of hormone therapy for prostate patients
- No evidence of metastatic disease
- No current severe mental illness
- No substance dependence within the past year -
Exclusion
- Does not meet inclusion criteria
- Psychotic Disorder
- Active Suicidal Ideation
- Substance dependence (alcohol/drugs) within the past 12 months
- Does not meet the requisite cutoff of 3 or more correct responses on SPMSQ (Short Portable Mental Status Questionnaire)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02275754
Start Date
November 1 2010
End Date
December 31 2017
Last Update
October 2 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60201
2
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229